Recent advances in nanotechnology based combination drug therapy for skin cancer

References

• Leider M. On the weight of the skin. J Invest Dermatol. 1949;12(3):187–191.
   PubMed Web of Science ®Google Scholar
• Dasari S, Yedjou CG, Brodell RT, et al. Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer. Nanotechnol Rev. 2020;9(1):1500–1521.
   PubMed Web of Science ®Google Scholar
• Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115–118.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog. Polym. Sci. 2014;39(2):268–307.
   Web of Science ®Google Scholar
• Kesharwani P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials. 2012;33(29):7138–7150.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Iyer AK. Recent advances in dendrimer-based nanovectors for tumour-targeted drug and gene delivery. Drug Discov Today. 2015a;20(5):536–547.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Banerjee S, Gupta U, et al. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics. Mater. Today. 2015b;18(10):565–572.
   Web of Science ®Google Scholar
• Kesharwani P, Tekade RK, Gajbhiye V, et al. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine. 2011;7(3):295–304.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Tekade RK, Jain NK. Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations. Pharm Res. 2015c;32(4):1438–1450.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Choudhury H, Meher JG, et al. Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging. Prog Mater Sci. 2019;103:484–508.
   Web of Science ®Google Scholar
• Wei X, Jianhong L, Davoudi Z, et al. Folate receptor-targeted and GSH-responsive carboxymethyl chitosan nanoparticles containing covalently entrapped 6-mercaptopurine for enhanced intracellular drug delivery in leukemia. Mar Drugs. 2018;16(11):439–456.
   PubMed Web of Science ®Google Scholar
• Liao J, Peng H, Wei X, et al. A bio-responsive 6-mercaptopurine/doxorubicin based "click chemistry" polymeric prodrug for cancer therapy. Mater Sci Eng C. 2020;108(1):110461–110473.
   PubMedGoogle Scholar
• Liao J, Peng H, Liu C, et al. Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy. Mater Sci Eng C Mater Biol Appl. 2021;118(1):111527–111540.
   PubMedGoogle Scholar
• Agrawal M, Saraf S, Saraf S, et al. Stimuli-responsive in situ gelling system for nose-to-brain drug delivery. J. Control. Release. 2020;327:235–265.
   PubMed Web of Science ®Google Scholar
• Borgheti-Cardoso LN, Viegas JSR, Silvestrini AVP, et al. Nanotechnology approaches in the current therapy of skin cancer. Adv Drug Deliv Rev. 2020;153:109–136.
   PubMed Web of Science ®Google Scholar
• Chadar R, Sheikh A, Kesharwani P. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer. Int. J. Pharm. 2021;605:120835.
   PubMedGoogle Scholar
• Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release. 2021;337:589–611.
   PubMed Web of Science ®Google Scholar
• Tripathi PK, Gorain B, Choudhury H, et al. Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. Heliyon. 2019;5(3):4: e01343. *
   PubMed Web of Science ®Google Scholar
• Ostrowski SM, Fisher DE. Biology of melanoma. Hematol Oncol Clin North Am. 2021;35(1):29–56.
   PubMed Web of Science ®Google Scholar
• Zhang T, Dutton-Regester K, Brown KM, et al. The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res. 2016;29(3):266–283.
   PubMed Web of Science ®Google Scholar
• Didona D, Paolino G, Bottoni U, et al. Non melanoma skin cancer pathogenesis overview. Biomedicines. 2018;6(1):6.
   PubMed Web of Science ®Google Scholar
• Apalla Z, Nashan D, Weller RB, et al. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb). 2017;7(Suppl 1):5–19.
   PubMed Web of Science ®Google Scholar
• Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303–317.
   PubMed Web of Science ®Google Scholar
• Cives M, Mannavola F, Lospalluti L, et al. Non-melanoma skin cancers: biological and clinical features. Int J Mol Sci. 2020;21:1–24.
   Web of Science ®Google Scholar
• Green AC, Olsen CM. Cutaneous squamous cell carcinoma: an epidemiological review. Br J Dermatol. 2017;177(2):373–381.
   PubMed Web of Science ®Google Scholar
• Kabir S, Schmults CD, Ruiz ES. A review of cutaneous squamous cell carcinoma epidemiology, diagnosis, and management. Int J Cancer Manag. 2018;11(1):e60846.
   Web of Science ®Google Scholar
• Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54(2):130–140.
   PubMed Web of Science ®Google Scholar
• Kauvar A, Cronin T, Roenigk R, et al. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41(5):550–571.
   PubMed Web of Science ®Google Scholar
• Aung P, Nagarajan P, Prieto V. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance. Lab Invest. 2017;97(6):657–668.
   Web of Science ®Google Scholar
• Seiverling EV, Ahrns HT, Bacik LC, et al. Biopsies for skin cancer detection: dispelling the myths. J Fam Pract. 2018;67(5):270–274.
   PubMed Web of Science ®Google Scholar
• Narayanamurthy V, Padmapriya P, Noorasafrin A, et al. Skin cancer detection using non-invasive techniques. RSC Adv. 2018;8(49):28095–28130.
   PubMed Web of Science ®Google Scholar
• Skandalis SS, Gialeli C, Theocharis ADT, et al. Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer. Adv Cancer Res. 2014;123:277–317.
   PubMed Web of Science ®Google Scholar
• Kumar A, Chen F, Mozhi A, et al. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale. 2013;5(18):8307–8325.
   PubMed Web of Science ®Google Scholar
• Liu Q, Xu N, Liu L, et al. Dacarbazine-loaded hollow mesoporous silica nanoparticles grafted with folic acid for enhancing antimetastatic melanoma response. ACS Appl Mater Interfaces. 2017;9(26):21673–21687.
   PubMed Web of Science ®Google Scholar
• Zhou M, Li X, Li Y, et al. Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy . Drug Deliv. 2017;24(1):1230–1242.
   PubMed Web of Science ®Google Scholar
• Jiang G, Li R, Jianqin T, et al. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells. Oncol Rep. 2017;37(2):995–1001.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Xiao Z, Valencia PM, et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41(7):2971–3010.
   PubMed Web of Science ®Google Scholar
• Tang S, Davoudi Z, Wang G, et al. Soft materials as biological and artificial membranes. Chem Soc Rev. 2021;50(22):12679–12701.
   PubMed Web of Science ®Google Scholar
• Grimaldi N, Andrade F, Segovia N, et al. Lipid-based nanovesicles for nanomedicine. Chem Soc Rev. 2016;45(23):6520–6545.
   PubMed Web of Science ®Google Scholar
• Sala M, Diab R, Elaissari A, et al. Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm. 2018;535(1-2):1–17.
   PubMed Web of Science ®Google Scholar
• Vyas A, Das SK, Singh D, et al. Recent nanoparticulate approaches of drug delivery for skin cancer. Trends Appl Sci Res. 2012;7(8):620–635.
   Google Scholar
• Olusanya TOB, Ahmad RRH, Ibegbu DM, et al. Liposomal drug delivery systems and anticancer drugs. Molecules. 2018;23(4):907–917.
   PubMed Web of Science ®Google Scholar
• Mirzavi F, Barati M, Soleimani A, et al. A review on liposome-based therapeutic approaches against malignant melanoma. Int J Pharm. 2021;599(120413):120413.
   PubMedGoogle Scholar
• Touitou E. Compositions for applying active substances to or through the skin. United States 1996. patent US 5540934 A.
   Google Scholar
• Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech. 2007;8(4):213.
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65(3):403–418.
   PubMed Web of Science ®Google Scholar
• Romero EL, Morilla MJ. Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations. Int J Nanomedicine. 2013;8:3171–3186.
   PubMed Web of Science ®Google Scholar
• Mbah CC, Builders PF, Attama AA. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Expert Opin Drug Deliv. 2014;11(1):45–59.
   PubMed Web of Science ®Google Scholar
• Pandey V, Golhani D, Shukla R. Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv. 2015;22(8):988–1002.
   PubMed Web of Science ®Google Scholar
• Paiva-Santos AC, Silva AL, Catarina G, et al. Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res. 2021;38(6):947–970.
   PubMed Web of Science ®Google Scholar
• Yeo PL, Lim CL, Chye SM, et al. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed (Res Rev News). 2018;11(4):301–314.
   Google Scholar
• Seleci DA, Seleci M, Walter J-G, et al. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J Nanomater. 2016;2016:1–13.
   Web of Science ®Google Scholar
• Mahale NB, Thakkar PD, Mali RG, et al. Niosomes: novel sustained release nonionic stable vesicular systems-an overview. Adv Colloid Interface Sci. 2012;183-184:46–54.
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Muzzalupo R, et al. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm. 2008;353(1-2):233–242.
   PubMedGoogle Scholar
• Solanki D, Kushwah L, Motiwale M, et al. Transferosomes-a review. World J Pharm Pharm Sci. 2016;5:435–449.
   Google Scholar
• Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev Exp. 2017;8(1):1325708.
   PubMed Web of Science ®Google Scholar
• Duan Y, Dhar A, Patel C, et al. A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems. RSC Adv. 2020;10(45):26777–26791.
   PubMed Web of Science ®Google Scholar
• Geszke-Moritz M, Moritz M. Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies. Mater Sci Eng C Mater Biol Appl. 2016;68:982–994.
   PubMed Web of Science ®Google Scholar
• Ekambaram P, Abdul A, Sathali H, et al. Solid lipid nanoparticles: a review. Sci Revs Chem Commun. 2012;2:80–102.
   Web of Science ®Google Scholar
• Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol. 2005;27(2):127–144.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system indian. Indian J Pharm Sci. 2009;71(4):349–358.
   PubMed Web of Science ®Google Scholar
• Montoto SS, Muraca G, Ruiz ME. Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects. Front Mol Biosci. 2020;7:587997.
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drug. Int J Pharm. 2002;242(1-2):121–128.
   PubMed Web of Science ®Google Scholar
• Radtke M, Muller RH. Comparison of structural properties of solid lipid nanoparticles (SLN) versus other lipid particles. Proc Int Symp Control Rel Bioact Mater. 2000;27:309–310.
   Google Scholar
• Uner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Pharmazie. 2006;61(5):375–386.
   PubMed Web of Science ®Google Scholar
• Purohit DK, Nandgude TD, Poddar SS. Nano-lipid carriers for topical application: current scenario. Asian J Pharm. 2016;9:1–9.
   Google Scholar
• Zauner W, Farrow NA, Haines AMR. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release. 2001;71(1):39–51.
   PubMed Web of Science ®Google Scholar
• Dubey N, Malviya, N, Majumdar. A. Nanostructure lipid carriers: a promising tool for the drug delivery in the treatment of skin cancer. Asian J Pharm Clin Res. 2019;12:15–26.
   Google Scholar
• El-Bahr SM. Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1. Phytother Res. 2015;29(1):134–140.
   PubMed Web of Science ®Google Scholar
• Talegaonkar S, Bhattacharyya A. Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability. AAPS Pharm SciTech. 2019;20:121.
   PubMed Web of Science ®Google Scholar
• Ekladious I, Colson YL, Grinstaff MW. Polymer-drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov. 2019;18(4):273–294.
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Hemasa AL, Freag MS. Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging. J Control Release. 2016;243:303–322.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761–769.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang N. How nanotechnology can enhance docetaxel therapy. Int J Nanomedicine. 2013;8:2927–2941.
   PubMed Web of Science ®Google Scholar
• Zhang L, Radovic-Moreno AF, Alexis F, et al. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem. 2007;2(9):1268–1271.
   PubMed Web of Science ®Google Scholar
• Mehan N, Kumar M, Bhatt S, et al. Self-Assembly polymeric nano micelles for the futuristic treatment of skin cancer and phototoxicity: Therapeutic and clinical advancement. Crit Rev Ther Drug Carrier Syst. 2022;39(2):79–95.
   PubMed Web of Science ®Google Scholar
• Nazir S, Hussain T, Ayub A, et al. Nanomaterials in combating cancer: therapeutic applications and developments. Nanomedicine. 2014;10(1):19–34.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56(11):1649–1659.
   PubMed Web of Science ®Google Scholar
• Deng S, Gigliobianco MR, Censi R, et al. Polymeric nanocapsules as nanotechnological alternative for drug delivery system: current status, challenges and opportunities. Nanomaterials. 2020;10(5):847–836.
   Web of Science ®Google Scholar
• Pohlmann AR, Weiss V, Mertins O, et al. Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: Development, stability evaluation and nanostructure models. Eur J Pharm Sci. 2002;16(4-5):305–312.
   PubMed Web of Science ®Google Scholar
• Gazzi RP, Frank LA, Onzi G, et al. New pectin-based hydrogel containing imiquimod-loaded polymeric nanocapsules for melanoma treatment. Drug Deliv Transl Res. 2020;10(6):1829–1840.
   PubMed Web of Science ®Google Scholar
• Mittal P, Saharan A, Verma R, et al. Dendrimers: a new race of pharmaceutical nanocarriers. Biomed Res Int. 2021;2021:8844030–8844012.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303(5665):1818–1822.
   PubMed Web of Science ®Google Scholar
• Singh R, Hildgen P. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery. Bioconjug Chem. 2006;17(1):29–41.
   PubMed Web of Science ®Google Scholar
• Bei D, Meng J, Youan BTC. Engineering nanomedicines for improved melanoma therapy: progress and promises. Nanomedicine (Lond). 2010;5(9):1385–1399.
   PubMed Web of Science ®Google Scholar
• Jain PK, Eustis S, El-Sayed MA. Plasmon coupling in nanorod assemblies: optical absorption, discrete dipole approximation simulation, and exciton-coupling model. J Phys Chem B. 2006;110(37):18243–18253.
   PubMed Web of Science ®Google Scholar
• Albrecht R. Immunocytochemistry: a practical approach (Edited by E. J. Beesley), vol. 2, chapter 7. Oxford (UK): Oxford University Press, 1993.
   Google Scholar
• Bagheri S, Yasemi M, Safaie-Qamsari E, et al. Using gold nanoparticles in diagnosis and treatment of melanoma cancer. Artif Cells Nanomed Biotechnol. 2018;46(sup1):462–471.
   PubMed Web of Science ®Google Scholar
• Lee SH, Jun BH. Silver nanoparticles: synthesis and application for nanomedicine. IJMS. 2019;20(4):865.
   Google Scholar
• Suresh AK, Pelletier DA, Wang W, et al. Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir. 2012;28(5):2727–2735.
   PubMed Web of Science ®Google Scholar
• Huang H, Barua S, Sharma G, et al. Inorganic nanoparticles for cancer imaging and therapy. J Control Release. 2011;155(3):344–357.
   PubMed Web of Science ®Google Scholar
• Kievit FM, Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res. 2011;44(10):853–862.
   PubMed Web of Science ®Google Scholar
• Chee CF, Leo BF, Lai CW. Superparamagnetic iron oxide nanoparticles for drug delivery. In Inamuddin I., Asiri A.M., Mohammad A., editors. Applications of nanocomposite materials in drug delivery. 1st ed. Woodhead Publishing; Cambridge (UK), 2018. pp 861–903.
   Google Scholar
• Raviraj V, Pham BTT, Kim BJ, et al. Non-invasive transdermal delivery of chemotherapeutic molecules in vivo using superparamagnetic iron oxide nanoparticles. Cancer Nano. 2021;12(1):1–15.
   PubMed Web of Science ®Google Scholar
• Farjadian JF, Roointan A, Mohammadi-Samani S, et al. Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem Eng J. 2019;359:684–705.
   Web of Science ®Google Scholar
• Shi Z, Zhou Y, Fan T, et al. Inorganic nano-carriers based smart drug delivery systems for tumor therapy. Smart Materials in Medicine. 2020;1:32–47.
   Google Scholar
• Marinheiro D, Ferreira B, Oskoei P, et al. Encapsulation and enhanced release of resveratrol from mesoporous silica nanoparticles for melanoma therapy. Materials. 2021;14(6):1382.
   PubMed Web of Science ®Google Scholar
• Kang Z, Lee S-T. Carbon dots: advances in nanocarbon applications. Nanoscale. 2019;11(41):19214–19224.
   PubMed Web of Science ®Google Scholar
• Maiti D, Tong X, Mou X, et al. Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol. 2019;9:1–16.
   Web of Science ®Google Scholar
• Polizu S, Savadogo O, Poulin P, et al. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. J Nanosci Nanotechnol. 2006;6(7):1883–1904.
   PubMed Web of Science ®Google Scholar
• Akhtar N, Pathak K. Carbon nanotubes in the treatment of skin cancers: safety and toxic ological aspects. Pharm Nanotechnol. 2017;5:95–110.
   PubMedGoogle Scholar
• Sharma A, Das J. Small molecules derived carbon dots: synthesis and applications in sensing, catalysis, imaging, and biomedicine. J Nanobiotechnol. 2019;17(1):24.
   PubMed Web of Science ®Google Scholar
• Loukanov AR, Gagov HS, Mishonova MY, et al. Biocompatible carbon nanodots for functional imaging and cancer therapy: carbon nanodots for imaging and cancer therapy. Int J Biomed Eng Technol. 2016;7:31–45.
   Google Scholar
• Zeng Q, Shao D, He X, et al. Carbon dots as a trackable drug delivery carrier for localized cancer therapy in vivo. J Mater Chem B. 2016;4(30):5119–5126.
   PubMed Web of Science ®Google Scholar
• Novoselov KS, Geim AK, Morozov SV, et al. Electric field effect in atomically thin carbon films. Science. 2004;306(5696):666–669.
   PubMed Web of Science ®Google Scholar
• Liu JZ, Dong J, Zhang T, et al. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy. J Control Release. 2018a;286:64–73.
   PubMed Web of Science ®Google Scholar
• Oliveira SF, Bisker G, Bakh NA, et al. Protein functionalized carbon nanomaterials for biomedical applications. Carbon. 2015;95:767–779.
   Web of Science ®Google Scholar
• Madni A, Tahir N, Rehman M, et al. Hybrid nano-carriers for potential drug delivery. Hybrid nano-carriers for potential drug delivery. Adv Technol Deliver Therapeut. 2017;53–87.
   Google Scholar
• Caddeo C, Nacher A, Vassallo A, et al. Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer. Int J Pharm. 2016;513(1-2):153–163.
   PubMed Web of Science ®Google Scholar
• Jose A, Labala S, Venuganti VVK. Co-Delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. J Drug Target. 2017;25(4):330–341.
   PubMed Web of Science ®Google Scholar
• Singh S. Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells. Int J Nanomedicine. 2018;13(T-NANO 2014 Abstracts):11–13.
   PubMedGoogle Scholar
• Duan X, Mu M, Yan J, et al. Co-delivery of Aurora-a inhibitor XY-4 and bcl-xl siRNA enhances antitumor efficacy for melanoma therapy. Int J Nanomedicine. 2018;13:1443–1456.
   PubMed Web of Science ®Google Scholar
• Mishra H, Mishra PK, Iqbal Z, et al. Co-delivery of eugenol and dacarbazine by hyaluronic acid-coated liposomes for targeted inhibition of survivin in treatment of resistant metastatic melanoma. Pharmaceutics. 2019;11(4):163.
   PubMed Web of Science ®Google Scholar
• Chen L, Alrbyawi H, Poudel I, et al. Co-delivery of doxorubicin and ceramide in a liposomal formulation enhances cytotoxicity in murine B16BL6 melanoma cell lines. AAPS Pharm Sci Tech. 2019;20:1–10.
   Web of Science ®Google Scholar
• Wang T, Feng L, Yang S, et al. Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency. Drug Deliv. 2017;24(1):800–810.
   PubMed Web of Science ®Google Scholar
• Carvalho VFM, Migotto A, Giacone DV, et al. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. Eur J Pharm Sci. 2017;109:131–143.
   PubMed Web of Science ®Google Scholar
• Lin H, Lin L, Choi Y, et al. Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma. Int J Pharm. 2020;581:119278.
   PubMedGoogle Scholar
• Imran M, Iqubal MK, Imtiyaz K, et al. Topical nanostructured lipid carrier gel of quercetin and resveratrol: formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int J Pharm. 2020;587:119705.
   PubMed Web of Science ®Google Scholar
• Tavakoli F, Jahanban-Esfahlan R, Seidi K, et al. Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. Artif Cells Nanomed Biotechnol. 2018;46(sup2):75–86.
   PubMed Web of Science ®Google Scholar
• Yin Y, Hu Q, Xu C, et al. Co-delivery of doxorubicin and interferon-γ by thermosensitive nanoparticles for cancer immunochemotherapy. Mol Pharm. 2018;15(9):4161–4172.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang X, Wang X, et al. Recent advances in selective photothermal therapy of tumor. J Nanobiotechnol. 2021;19(1):1–15.
   PubMed Web of Science ®Google Scholar
• Xia C, Yin S, Xu S, et al. Low molecular weight heparin-coated and dendrimer-based core-shell nanoplatform with enhanced immune activation and multiple anti-metastatic effects for melanoma treatment. Theranostics. 2019;9(2):337–354.
   PubMed Web of Science ®Google Scholar
• Lu Y, Yang Y, Gu Z, et al. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and co-delivery platform for enhanced cancer immunotherapy. Biomaterials. 2018;175:82–92.
   PubMed Web of Science ®Google Scholar
• Labala S, Mandapalli PK, Kurumaddali A, et al. Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma. Mol Pharmaceutics. 2015;12(3):878–888.
   PubMed Web of Science ®Google Scholar
• Preet S, Pandey SK, Kaur K, et al. Gold nanoparticles assisted co-delivery of nisin and doxorubicin against murine skin cancer. J Drug Deliv Sci Technol. 2019;53:101147.
   Web of Science ®Google Scholar
• Hesabi M, Hesabi M. The interaction between carbon nanotube and skin anti-cancer drugs: a DFT and NBO approach. J. Nanostructure Chem. 2013;3:1–6.
   Google Scholar
• Li H, Li Y, Wang X, et al. Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy. Theranostics. 2017;7(18):4383–4398.
   PubMed Web of Science ®Google Scholar
• Wang S, Xin J, Zhang L, et al. Cantharidin-encapsulated thermal-sensitive liposomes coated with gold nanoparticles for enhanced photothermal therapy on A431 cells . Int J Nanomedicine. 2018;13:2143–2160.
   PubMed Web of Science ®Google Scholar
• Rao J, Mei L, Liu J, et al. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention. Acta Biomater. 2019;89:300–312.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Song Q, Yin Y, et al. Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects. J Control Release. 2018;269:322–336.
   PubMed Web of Science ®Google Scholar
• Beack S, Kong WH, Jung HS, et al. Photodynamic therapy of melanoma skin cancer using carbon dot - chlorin e6 - hyaluronate conjugate. Acta Biomater. 2015;26:295–305.
   PubMed Web of Science ®Google Scholar
• Goto PL, Siqueira-Moura MP, Tedesco AC. Application of aluminum chloride phthalocyanine-loaded solid lipid nanoparticles for photodynamic inactivation of melanoma cells. Int J Pharm. 2017;518(1–2):228–241.
   PubMedGoogle Scholar
• Rady M, Gomaa I, Afifi N, et al. Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model. Int J Pharm. 2018;548(1):480–490.
   PubMedGoogle Scholar
• Sebak AA, Gomaa IEO, ElMeshad AN, et al. ElMeshad an, et al targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma. Photodiagnosis Photodyn Ther. 2018;23:181–189.
   PubMed Web of Science ®Google Scholar
• Bazylińska U, Kulbacka J, Schmidt J, et al. Polymer-free cubosomes for simultaneous bioimaging and photodynamic action of photosensitizers in melanoma skin cancer cells. J Colloid Interface Sci. 2018;522:163–173.
   PubMed Web of Science ®Google Scholar
• Singh SP, Alvi SB, Pemmaraju DB, et al. NIR triggered liposome gold nanoparticles entrapping curcumin as in situ adjuvant for photothermal treatment of skin cancer. Int J Biol Macromol. 2018;110:375–382.
   PubMed Web of Science ®Google Scholar
• Rahimi-Moghaddam F, Azarpira N, Sattarahmady N. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation. Lasers Med Sci. 2018;33(8):1769–1779.
   PubMed Web of Science ®Google Scholar
• Zhou B, Song J, Wang M, et al. BSA-bioinspired gold nanorods loaded with immunoadjuvant for the treatment of melanoma by combined photothermal therapy and immunotherapy. Nanoscale. 2018;10(46):21640–21647.
   PubMed Web of Science ®Google Scholar
• Zang Y, Wei Y, Shi Y, et al. Chemo/photoacoustic dual therapy with mRNA-triggered DOX release and photoinduced shockwave based on a DNA-Gold Nanoplatform. Small. 2016;12(6):756–769.
   PubMed Web of Science ®Google Scholar
• Venuganti VVK, Saraswathy M, Dwivedi C, et al. Topical gene silencing by iontophoretic delivery of an antisense oligonucleotide-dendrimer nanocomplex: the proof of concept in a skin cancer mouse model. Nanoscale. 2015;7(9):3903–3914.
   PubMed Web of Science ®Google Scholar
• Labala S, Jose A, Chawla SR, et al. Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles. Int J Pharm. 2017;525(2):407–417.
   PubMedGoogle Scholar
• Petrilli R, Eloy JO, Saggioro FP, et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. J Control Release. 2018;283:151–162.
   PubMed Web of Science ®Google Scholar
• Liu M, Khan AR, Ji J, et al. Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses. J Control Release. 2018b;290:150–164.
   PubMed Web of Science ®Google Scholar
• Prasad C, Banerjee R. Ultrasound triggered spatiotemporal delivery of topotecan and curcumin as combination therapy for cancer. J Pharmacol Exp Ther. 2019;370(3):876–893.
   PubMed Web of Science ®Google Scholar
• Hao Y, Li W, Zhou XL, et al. Microneedles-based transdermal drug delivery systems: a review. J Biomed Nanotechnol. 2017;13(12):1581–1597.
   PubMed Web of Science ®Google Scholar
• Tham HP, Xu K, Lim WQ, et al. Microneedle-assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma. ACS Nano. 2018;12(12):11936–11948.
   PubMed Web of Science ®Google Scholar
• Lan X, She J, Lin DA, et al. Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy. ACS Appl Mater Interfaces. 2018;10(39):33060–33069.
   PubMed Web of Science ®Google Scholar
• Ahmed KS, Shan X, Mao J, et al. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Mater Sci Eng C Mater Biol Appl. 2019;99:1448–1458.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Xu Z, et al. mRNA vaccine with antigen-specific checkpoint blockade induces an enhanced immune response against established melanoma. Mol Ther. 2018;26(2):420–434.
   PubMed Web of Science ®Google Scholar
• Byrne JD, Yeh JJ, DeSimone JM. Use of iontophoresis for the treatment of cancer. J Control Release. 2018;284:144–151.
   PubMed Web of Science ®Google Scholar
• Jose A, Labala S, Ninave KM, et al. Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes. AAPS Pharm Sci Tech. 2018;19(1):166–175.
   PubMed Web of Science ®Google Scholar
• Carter P, Narasimhan B, Wang Q. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases. Int J Pharm. 2019;555(1):49–62.
   PubMedGoogle Scholar